News
Namenda and Aricept have been approved by the Food and Drug Administration (FDA) to treat the following. Here’s a quick look at the dosage and administration of Namenda and Aricept for the ...
In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...
Namenda XR) are both used to treat dementia symptoms in people with Alzheimer’s disease, but they work in different ways. One drug may be better at helping certain symptoms than the other drug.
To recommend the right drug for you or your loved one ... one’s doctor may also prescribe a glutamate regulator called memantine (often sold under brand names like Namenda and Valios).
He emphasized the need for further research to develop a safe and effective energy-restoring drug for humans ... including Namenda®. His team’s findings highlight mitochondrial metabolism ...
New York-based Forest Laboratories is testing Namenda (memantine), an Alzheimer's drug and N-methyl D-aspartate receptor (NMDA) receptor modulator, in a phase 2 trial in autism patients.
Antidementia drug prescribing was recorded as present if the patient had received such a drug (cholinesterase inhibitor or memantine) and continued to take it beyond the initiation phase. Parkinson’s ...
Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...
Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results